eResearch Technology (ERT +16.9%) shares soar after Q4 results beat analyst estimates and...

|About: eResearch Technology Inc. (ERT)|By:, SA News Editor

eResearch Technology (ERT +16.9%) shares soar after Q4 results beat analyst estimates and Benchmark says it believes underlying clinical research industry trends recovered late in 2011 and have now returned to a favorable track. In raising shares to Buy, the firm expects improved margins, profitability and cash flow with the recent release of the Expert3 platform.